Dr.Matthias Preusser (Clinical oncologist, Neurooncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

• Current Position:
  • Professor of Medical Oncology, Medical University of Vienna
  • Head of the Clinical Division of Oncology, Medical University of Vienna
  • Coordinator of the Brain Tumor Unit, Comprehensive Cancer Center – Central Nervous System (CCC-CNS)
• Previous Roles:
  • Associate Professor, Medical University of Vienna
  • Senior Physician, Department of Oncology, AKH Vienna
• Clinical Contributions:
  • Overseeing numerous clinical trials in neuro-oncology
  • Leading international randomized studies on glioblastoma and meningiomas

Academic Contributions

• Teaching Positions:
  • Lecturer in Medical Oncology, Medical University of Vienna
• Research Interests:
  • Biomarkers in brain tumors
  • Immunotherapy and personalized cancer treatment
  • Development of epigenetic classification systems for cancers
• Course Development and Speaking Engagements:
  • Regular speaker at international oncology conferences
  • Contributor to educational programs in neuro-oncology

Areas of Expertise

• Conditions Treated:
  • Glioblastoma
  • Meningiomas
  • Brain metastases
• Specialized Procedures:
  • Personalized immunotherapy regimens
  • Radioligand therapy for brain tumors
• Patient-Centric Examples:
  • Implementing targeted therapies based on genetic profiling
  • Utilizing advanced imaging techniques for precise tumor localization

Publications and Research

Prof. Dr. Matthias Preusser has authored numerous peer-reviewed articles and book chapters, contributing significantly to the field of neuro-oncology. Notable publications include:

• MGMT and IDH Gene Studies in Gliomas: Research on the role of MGMT and IDH genes in glioblastoma multiforme, providing insights into prognostic markers and therapeutic targets.
• WHO Brain Tumor Classification: Co-authorship of the current WHO classification of brain tumors, serving as an international standard reference.
• TUXEDO-1 Study: Leading the TUXEDO-1 study, which established trastuzumab deruxtecan as a treatment option for brain metastases from breast cancer.

Patient Care Philosophy

Prof. Dr. Matthias Preusser is committed to providing compassionate and personalized care to his patients. His approach includes:

• Communication: Ensuring clear and open dialogue with patients and their families.
• Empathy: Understanding and addressing the emotional and psychological needs of patients.
• Patient Education: Empowering patients with knowledge about their condition and treatment options.
• International Patients: Offering online pre-consultations and culturally sensitive care to international patients.

Professional Affiliations

• European Society for Medical Oncology (ESMO)
• European Organisation for Research and Treatment of Cancer (EORTC)
• European Association of Neuro-Oncology (EANO) – President 2021/2022
• Society of Austrian Neuro-Oncology (SANO) – Co-founder and first secretary
• Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie (ÖGHO)
• Central European Cooperative Oncology Group (CECOG)

FAQs

Is Dr. Matthias Preusser board-certified?

Yes, Dr. Preusser is board-certified in internal medicine, hematology, and medical oncology.

What types of surgeries does he perform?

Dr. Preusser specializes in oncological surgeries related to brain tumors, including glioblastoma and meningiomas.

Does he treat international patients?

Yes, Dr. Preusser provides care to international patients and offers online pre-consultations.

How long is the typical hospital stay?

The length of hospital stay varies depending on the specific procedure and patient condition.

What languages does he speak?

Dr. Preusser is proficient in German and English.